• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA030抑制组织蛋白酶B的2.0埃分辨率晶体结构:特异性环氧琥珀酰抑制剂设计的基础

Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.

作者信息

Turk D, Podobnik M, Popovic T, Katunuma N, Bode W, Huber R, Turk V

机构信息

Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Ljubljana, Slovenia.

出版信息

Biochemistry. 1995 Apr 11;34(14):4791-7. doi: 10.1021/bi00014a037.

DOI:10.1021/bi00014a037
PMID:7718586
Abstract

Crystals of cysteine protease human cathepsin B inhibited with CA030 (ethyl ester of epoxysuccinyl-Ile-Pro-OH) [Murata, M., et al. (1991) FEBS Lett. 280, 307-310; Towatari, T., et al. (1991) FEBS Lett. 280, 311-315] were isomorphous to a previous published structure of cathepsin B [Musil, D., et al. (1991) EMBO J. 10, 2321-2330]. The crystal structure of the complex was refined at 2.0-A resolution to an R-value of 0.194. CA030 is well-defined in the electron density. The Ile-Pro-OH part of CA030 mimics a substrate P1' and P2' residues. The structure thus reveals for the first time a substratelike interaction in the S1' and S2' sites of a papain-like cysteine protease. The CA030 ethyl ester group occupies the S2 site. The structure confirms the role of residues His 110 and His 111 as the receptors of a peptidic substrate C-terminal carboxylic group. The structure suggests that an epoxysuccinyl fragment can be used to extend binding into primed and nonprimed substrate binding sites of a papain-like cysteine protease.

摘要

用CA030(环氧琥珀酰 - 异亮氨酸 - 脯氨酸 - 羟基乙酯)抑制的人组织蛋白酶B半胱氨酸蛋白酶晶体[村田,M.等人(1991年)《欧洲生物化学学会联合会快报》280,307 - 310;户刈,T.等人(1991年)《欧洲生物化学学会联合会快报》280,311 - 315]与先前发表的组织蛋白酶B结构[穆西尔,D.等人(1991年)《欧洲分子生物学组织杂志》10,2321 - 2330]同晶型。该复合物的晶体结构在2.0埃分辨率下精修至R值为0.194。CA030在电子密度图中定义明确。CA030的异亮氨酸 - 脯氨酸 - 羟基部分模拟底物的P1'和P2'残基。因此,该结构首次揭示了类木瓜蛋白酶半胱氨酸蛋白酶S1'和S2'位点中的底物样相互作用。CA030乙酯基团占据S2位点。该结构证实了His 110和His 111残基作为肽底物C末端羧基受体的作用。该结构表明环氧琥珀酰片段可用于扩展与类木瓜蛋白酶半胱氨酸蛋白酶的引发和未引发底物结合位点的结合。

相似文献

1
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.CA030抑制组织蛋白酶B的2.0埃分辨率晶体结构:特异性环氧琥珀酰抑制剂设计的基础
Biochemistry. 1995 Apr 11;34(14):4791-7. doi: 10.1021/bi00014a037.
2
Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.基于环氧琥珀酰抑制剂的抑制活性-结合模式关系,通过复合物的X射线晶体结构分析对组织蛋白酶B的每个催化亚位点的抑制活性进行定量评估。
J Mol Biol. 2006 Oct 6;362(5):979-93. doi: 10.1016/j.jmb.2006.07.070. Epub 2006 Aug 1.
3
Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.野生型人组织蛋白酶B在2.5埃分辨率下的晶体结构揭示了一种木瓜蛋白酶样半胱氨酸蛋白酶原的天然活性位点。
J Mol Biol. 1997 Sep 5;271(5):774-88. doi: 10.1006/jmbi.1997.1218.
4
Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.NS-134与牛组织蛋白酶B复合物的晶体结构:一种双头环氧琥珀酰抑制剂沿整个活性位点裂缝延伸。
Biochem J. 2004 Jul 15;381(Pt 2):511-7. doi: 10.1042/BJ20040237.
5
Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B.环氧琥珀酰二肽作为组织蛋白酶B的选择性抑制剂
J Med Chem. 1993 Mar 19;36(6):720-5. doi: 10.1021/jm00058a008.
6
Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex.组织蛋白酶B特异性非共价型抑制剂开发的结构基础:组织蛋白酶B-E64c复合物的晶体结构
Biochim Biophys Acta. 2002 Jun 3;1597(2):244-51. doi: 10.1016/s0167-4838(02)00284-4.
7
Molecular design of potent inhibitor specific for cathepsin B based on the tertiary structure prediction.基于三级结构预测的组织蛋白酶B特异性强效抑制剂的分子设计
Chem Pharm Bull (Tokyo). 1992 Feb;40(2):299-303. doi: 10.1248/cpb.40.299.
8
The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.人肝脏组织半胱氨酸蛋白酶B的2.15埃X射线晶体结构精修:其特异性的结构基础
EMBO J. 1991 Sep;10(9):2321-30. doi: 10.1002/j.1460-2075.1991.tb07771.x.
9
Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.人组织蛋白酶B原在3.2埃和3.3埃分辨率下的晶体结构揭示了木瓜蛋白酶样半胱氨酸蛋白酶与其前肽之间的一种相互作用基序。
FEBS Lett. 1996 Apr 22;384(3):211-4. doi: 10.1016/0014-5793(96)00309-2.
10
X-ray crystal structure of papain complexed with cathepsin B-specific covalent-type inhibitor: substrate specificity and inhibitory activity.木瓜蛋白酶与组织蛋白酶B特异性共价型抑制剂复合物的X射线晶体结构:底物特异性和抑制活性。
Biochim Biophys Acta. 1998 Mar 3;1383(1):93-100. doi: 10.1016/s0167-4838(97)00187-8.

引用本文的文献

1
Redirecting the Peptide Cleavage Causes Protease Inactivation.重定向肽切割会导致蛋白酶失活。
Angew Chem Int Ed Engl. 2025 Jul 28;64(31):e202506832. doi: 10.1002/anie.202506832. Epub 2025 Jul 4.
2
Unveiling Cathepsin B inhibition with repurposed drugs for anticancer and anti-Alzheimer's drug discovery.揭示用重新利用的药物抑制组织蛋白酶B以用于抗癌和抗阿尔茨海默病药物研发。
PLoS One. 2024 Dec 19;19(12):e0316010. doi: 10.1371/journal.pone.0316010. eCollection 2024.
3
Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis.
受自然启发的 Gallinamides 是有效的抗血吸虫药物:对组织蛋白酶 B1 蛋白酶靶标的抑制作用及结合模式分析。
ACS Infect Dis. 2024 Jun 14;10(6):1935-1948. doi: 10.1021/acsinfecdis.3c00589. Epub 2024 May 17.
4
Ginsenosides Rg1 and Rg2 Activate Autophagy and Attenuate Oxidative Stress in Neuroblastoma Cells Overexpressing Aβ(1-42).人参皂苷Rg1和Rg2激活自噬并减轻过表达Aβ(1-42)的神经母细胞瘤细胞中的氧化应激。
Antioxidants (Basel). 2024 Mar 1;13(3):310. doi: 10.3390/antiox13030310.
5
Role of Cathepsin B Expression in Oral Squamous Cell Carcinoma: A Comprehensive Review.组织蛋白酶B表达在口腔鳞状细胞癌中的作用:综述
Cureus. 2024 Feb 15;16(2):e54267. doi: 10.7759/cureus.54267. eCollection 2024 Feb.
6
The Role of Cysteine Protease Cathepsins B, H, C, and X/Z in Neurodegenerative Diseases and Cancer.半胱氨酸蛋白酶 Cathepsins B、H、C 和 X/Z 在神经退行性疾病和癌症中的作用。
Int J Mol Sci. 2023 Oct 26;24(21):15613. doi: 10.3390/ijms242115613.
7
Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment.响应组织蛋白酶B活性的癌症治疗智能递送系统
Pharmaceutics. 2023 Jun 29;15(7):1848. doi: 10.3390/pharmaceutics15071848.
8
Structure determinants defining the specificity of papain-like cysteine proteases.决定木瓜蛋白酶样半胱氨酸蛋白酶特异性的结构决定因素。
Comput Struct Biotechnol J. 2022 Nov 24;20:6552-6569. doi: 10.1016/j.csbj.2022.11.040. eCollection 2022.
9
Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitization.通过肿瘤微环境组织蛋白酶 B 使细胞通透性差的金纳米棒解封闭,促进癌细胞渗透和有效的放射增敏。
Biomaterials. 2022 Dec;291:121887. doi: 10.1016/j.biomaterials.2022.121887. Epub 2022 Nov 2.
10
Targeting Proteolysis with Cyanogenic Glycoside Amygdalin Induces Apoptosis in Breast Cancer Cells.氰苷苦杏仁苷通过靶向蛋白水解诱导乳腺癌细胞凋亡。
Molecules. 2022 Nov 5;27(21):7591. doi: 10.3390/molecules27217591.